<SEC-DOCUMENT>0001178913-25-001182.txt : 20250403
<SEC-HEADER>0001178913-25-001182.hdr.sgml : 20250403
<ACCEPTANCE-DATETIME>20250403070913
ACCESSION NUMBER:		0001178913-25-001182
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250403
FILED AS OF DATE:		20250403
DATE AS OF CHANGE:		20250403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IM Cannabis Corp.
		CENTRAL INDEX KEY:			0001792030
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40065
		FILM NUMBER:		25807500

	BUSINESS ADDRESS:	
		STREET 1:		KIBBUTZ GLIL YAM
		CITY:			CENTRAL DISTRICT
		STATE:			L3
		ZIP:			4690500
		BUSINESS PHONE:		416-256-4202

	MAIL ADDRESS:	
		STREET 1:		KIBBUTZ GLIL YAM
		CITY:			CENTRAL DISTRICT
		STATE:			L3
		ZIP:			4690500
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2532964.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">UNITED STATES</font><font style="font-family: 'Times New Roman', Times, serif;"><br>
        </font><font style="font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-family: 'Times New Roman', Times, serif;"><br>
        </font>Washington, D.C. 20549<font style="font-family: 'Times New Roman', Times, serif;"><br>
        <br>
        </font></div>
      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><font style="font-size: 14pt; font-weight: bold;">Form 6-K</font><br style="line-height: 1.25;">
        <font style="font-family: 'Times New Roman', Times, serif;"><br>
        </font><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16</font><font style="font-family: 'Times New Roman', Times, serif;"><br>
        </font><font style="font-family: 'Times New Roman', Times, serif; font-weight: bold;">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">For the month of <font style="font-weight: bold;"><u>March 2025</u></font>.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Commission File Number: <font style="font-weight: bold;"><u>001-40065</u></font><br style="line-height: 1.25;">
        <br>
        <font style="font-size: 16pt; font-family: 'Times New Roman',Times,serif; font-weight: bold;"><u>IM Cannabis Corp.</u></font><br>
        (Exact Name of Registrant as Specified in Charter)<br>
        <br>
        <font style="font-weight: bold;"><u>Kibbutz Glil Yam, Central District, Israel 4690500</u></font><br>
        (Address of principal executive offices)</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: center; line-height: 1.25;">Form 20-F &#9746;&#160;&#160;&#160;&#160; Form 40-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Note</font>: Regulation S-T Rule
        101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Note</font>: Regulation S-T Rule
        101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is
        incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not
        required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
        be signed on its behalf by the undersigned, thereunto duly authorized.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zd2a4a3b5eeac466bbf46c0e22e093869" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 45%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="vertical-align: middle;" colspan="2">
              <div style="line-height: 1.25; font-weight: bold;">IM CANNABIS CORP.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 45%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="vertical-align: middle;" colspan="2">
              <div style="line-height: 1.25;">(Registrant)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 45%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">Date:</div>
            </td>
            <td style="width: 45%; vertical-align: middle;">
              <div style="line-height: 1.25;">April 3, 2025</div>
            </td>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">By:</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle; border-bottom: #000000 2px solid;">
              <div style="line-height: 1.25; font-style: italic;">/s/ Oren Shuster</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 45%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">Name:</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle;">
              <div style="line-height: 1.25;">Oren Shuster</div>
            </td>
          </tr>
          <tr>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 45%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 5%; vertical-align: middle;">
              <div style="line-height: 1.25;">Title:</div>
            </td>
            <td style="width: 44.53%; vertical-align: middle;">
              <div style="line-height: 1.25;">Chief Executive Officer and Director</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;"><u>EXHIBIT INDEX</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zc49ddaa68be54fab8a83e43ec7a6ceba" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 7%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">99.1</a></div>
            </td>
            <td style="width: 93%; vertical-align: middle; background-color: rgb(204, 238, 255);">
              <div style="line-height: 1.25;"><a href="exhibit_99-1.htm">Form 7 - Monthly
                  Progress Report dated April 3, 2025</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit_99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Z-K GLOBAL
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div style="text-align: right;"><u><font style="font-weight: bold;">Exhibit 99.1</font></u><br>
    </div>
    <div>
      <div class="BRPFPageHeader">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25; font-weight: bold;">FORM 7<br style="line-height: 1.25;">
        <br>
        <u>MONTHLY PROGRESS REPORT</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Name of Listed Issuer: IM Cannabis Corp. (the &#8220;<font style="font-weight: bold;">Issuer</font>&#8221; or &#8220;<font style="font-weight: bold;">IMC</font>&#8221; or the "<font style="font-weight: bold;">Company</font>")</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Trading Symbol: IMCC</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Number of Outstanding Listed Securities as of 03/31/2025: 3,085,452 Common Shares.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25;">Date: April 3, 2025</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25; font-weight: bold;">Report on Business</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z722199f0f40747c1b6a0a4bb9bf1248b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Provide a general overview and discussion of the development of the Issuer&#8217;s business and operations over the previous month. Where the Issuer was inactive disclose
                this fact.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z6735344058454c9997e743ef2416e0aa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">On March 31, 2025, the Issuer announced financial results for the three months and fiscal year ended December 31, 2024.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zfd338f8ec2c84d50a0cef73e9d2f8282" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Provide a general overview and discussion of the activities of management.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;">Management of the
          Issuer (&#8220;Management&#8221;) is focused on continuing the Issuer&#8217;s growth in the cannabis markets in which it currently operates. Management is focused on managing its international assets and supply chain in order to maximize Issuer-wide revenue and
          margins and continues to focus on its entry into the medical cannabis distribution and retail segments in Israel. Management also continues to identify and pursue new strategic investments and growth opportunities in Israel and Germany,
          including, but not limited to, securing additional supply, distribution and sale agreements in Germany through Adjupharm GmbH and in Israel through its subsidiaries.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;">Management is
          seeking to focus its resources and maximize efficiency for future success. Management is reinforcing its Israeli and German operations and preparing to leverage its expertise into building market leadership in the European</font>&#160;<font style="font-weight: bold;">medical cannabis market and to be fully ready to capitalize on the
          recreational market following legalization.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z232ed37a4ab74fa0822c461cdd3f9d0c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production
                programs and acquisitions of any new properties and attach any mineral or oil and gas or other reports required under Ontario securities law.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">In March 2025, the Issuer launched a high-THC premium cannabis strains in Israel, called
        "ESPRESSO CNDY", "MED CO T15", "F.VIC" and re-launched "RAINBOW P", "BLK MLK", "GUAVA BOMBA" and "LA WOMAC".</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z6f1ec0b2e3664858bbe15bba4c4817dc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe and provide details of any products or services that were discontinued. For resource companies, provide details of any drilling, exploration or production
                programs that have been amended or abandoned.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z9b33ee8e878947b5bc19f07a344f8b06" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">5.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe any new business relationships entered into between the Issuer, the Issuer&#8217;s affiliates or third parties including contracts to supply products or services,
                joint venture agreements and licensing agreements etc. State whether the relationship is with a Related Person of the Issuer and provide details of the relationship.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z441d283db0d84135ac73cc2ef6719782" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">6.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe the expiry or termination of any contracts or agreements between the Issuer, the Issuer&#8217;s affiliates or third parties or cancellation of any financing
                arrangements that have been previously announced.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="za76543d7064f43a68c70091d5c229d09" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">7.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe any acquisitions by the Issuer or dispositions of the Issuer&#8217;s assets that occurred during the preceding month. Provide details of the nature of the assets
                acquired or disposed of and provide details of the consideration paid or payable together with a schedule of payments if applicable, and of any valuation. State how the consideration was determined and whether the acquisition was from or
                the disposition was to a Related Person of the Issuer and provide details of the relationship.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z224c840aae194dd6bfc0de61a47b1478" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">8.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe the acquisition of new customers or loss of customers.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zac4eef75d200486dba2c66a1a2142a32" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">9.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe any new developments or effects on intangible products such as brand names, circulation lists, copyrights, franchises, licenses, patents, software,
                subscription lists and trade-marks.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z34922d30192740139f4ed579c9621338" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">10.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Report on any employee hirings, terminations or lay-offs with details of anticipated length of lay-offs.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">In March 2025, the Issuer hired 0 new employees, and 0 resignation or termination of employee
        occurred.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1f8e79c23954443b80e2a6bffde4a6da" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">11.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Report on any labour disputes and resolutions of those disputes if applicable.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" id="z4e6a2e2b4c184ffe8b46721d1d661c20" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">12.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Describe and provide details of legal proceedings to which the Issuer became a party, including the name of the court or agency, the date instituted, the principal
                parties to the proceedings, the nature of the claim, the amount claimed, if any, if the proceedings are being contested, and the present status of the proceedings.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z74d8d51dfc1b40ec8967c793b0ded3e5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">13.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Provide details of any indebtedness incurred or repaid by the Issuer together with the terms of such indebtedness.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf75b30b532934f34839e7b6a5ed0259d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">14.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Provide details of any securities issued and options or warrants granted.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zf54755f148724d0f9f1be3407b75de8d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">15.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Provide details of any loans to or by Related Persons.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z7649e1f511594103b400f1e56dd18159" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">16.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Provide details of any changes in directors, officers or committee members.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Not Applicable.</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="ze02d015ec200413684c8173f79c1e5c0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">17.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>Discuss any trends which are likely to impact the Issuer including trends in the Issuer&#8217;s market(s) or political/regulatory trends.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">Global economies are currently experiencing elevated levels of inflation, including in the
        Issuer&#8217;s primary production markets, which could curtail levels of economic activity. Inflation concerns are in part driven by the increase in the cost of goods as input costs continue to increase due to several external factors, including but not
        limited to, general uncertainties caused by the Ukraine war, the global supply chain constrictions and rising energy prices. As such, delivery and distribution costs, utility costs and other necessary supplies at an economic cost cannot be assured.
        The impact of inflation and supply shortages on the integral components of the Issuer&#8217;s business could reasonably impact the Issuer&#8217;s future economic performance and competitiveness, as it may entail a meaningful increase in costs for various goods
        and services that the Issuer may not be able to pass onto patients or customers. In addition, the Issuer&#8217;s operations could also be affected should interest rates, inflation or unemployment reach levels that change consumer trends and spending and
        subsequently impact the sales and profitability of the Issuer.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">The war in Ukraine may also have a material adverse effect on global economic activity and could
        result in volatility and disruption to global supply chains and the financial and capital markets. These disruptions could cause interruptions in supplies and other services from third parties upon which the Issuer relies; decrease demand for
        products; and cause staff shortages, reduced customer traffic and increased government regulation, all of which may materially and negatively impact the business, financial condition and results of operations of the Issuer, its subsidiaries and
        Focus Medical.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">As of February 2023, and to date, Israel is undergoing political and social instability relating
        to the judicial and legislative reforms proposed by the newly elected government, creating certain instability and uncertainty. This instability which has a certain effect on the activity of the financial markets may cause material impact on the
        Issuers&#8217; ability to operate in the Israeli market.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On October 7, 2023, a war between the terror organization Hamas and Israel began. This war has
        an impact on the company's business operations. The company has suffered a negative impact since its started and until this day, however, there might be a potential positive effect in the medium to long term. The company has experienced damages to
        its ability to function, affecting various aspects, including employees, supplies, imports, sales, and more. While there are damages, it is still too early to fully assess the extent of their impact.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;"><font style="font-weight: bold;">The Israeli
          ministry of health announced the anticipated medical cannabis regulatory reform on August 7, 2023 (the "Reform"). The new regulations are expected to remove many of the heavy regulations in the sector, making medical cannabis more accessible to patients as well as boosting export, all
          of which may materially and positively impact the business, financial condition and results of operations of the Issuer, its subsidiaries and Focus Medical. On December 8, 2023, the Issuer announced</font>&#160;<font style="font-weight: bold;">a 3-month delay of the anticipated Reform that was originally scheduled for December 29, 2023, due to the Israel-Hamas war.</font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On April 1<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">st</sup>, 2024 the issuer announced that the Reform will be implemented in
        phases, as approved and announced by the Israeli Ministry of Health. The key aspects of the initial phase, commencing April 1st, are as follows:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z19ec264ebbf24770b3e50ac0c780d257" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-weight: bold;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Change in the prescription process: patients with a wide range of diseases and medical conditions from Oncology to Parkinsons will no longer be
                required to obtain a license to receive medical cannabis. Patients will receive a prescription similar to those for other prescription medications. Pain and PTSD are not included in the Reform yet.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="zc0ae426a56f54c74b8ebb4e93080dcce" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-weight: bold;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">Medical cannabis will now be prescribed through the HMO&#8217;s, Israel&#8217;s public healthcare system: until the Reform, cannabis could not be prescribed
                through the HMO&#8217;s which cover the entire Israeli population.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1a7b1f9fbee842e4a0ead50ec51c9821" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-weight: bold;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">The number of prescribing physicians will increase: as of today, HMO physicians, who are dully trained and certified within their field of
                expertise, can prescribe medical cannabis as a first line treatment, as opposed to a last resort, based on medical discretion for the approved indications.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z45a96d9d3d1242c7bfc235d65a949293" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 35.45pt;"><br>
            </td>
            <td style="width: 18pt; vertical-align: top; font-weight: bold;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-weight: bold;">The cost for prescription will be reduced: the Ministry of Health limited the cost for a medical cannabis prescription.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-style: italic; font-weight: bold;"><u>"Anti-Dumping&#8221; investigation into cannabis imports from Canada</u></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On January 18, 2024 , The Commissioner for Trade Levies at the Ministry of Economy and Industry,
        announced by virtue of his authority according to Section 24(d) of the Law on Trade Levies and Defence Measures, 5591 &#8211; 1991, of his decision to open an investigation on his own initiative into the export import of cannabis from Canada, after he
        found that special circumstances of actual damage exist or the probability of actual damage to the local manufacturing industry and a causal link between the imported imports and said damage. The Ministry of Economy and Industry issued a formal
        notice to the public to respond to questionnaires regarding the "Anti-Dumping" investigation. The Issuer has submitted on March 10, 2024, the relevant questionnaires regarding Focus Medical Herbal Ltd, IMC Pharma Ltd and Rosen High Way Ltd, it's
        related company and subsidiaries, respectively.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On June 18, 2024, the Ministry of Economy and Industry announced that it has decided to postpone
        the final deadline for obtaining its preliminary decision until July 18, 2024.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On July 10<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>, 2024, the Commissioner published a preliminary decision regarding the investigation and findings determining that there is dumping and consequent injury, on the basis of
          best information available. The Company is evaluating the preliminary decision and its potential impact on the Company and its subsidiaries. Focus Medical Herbs Ltd. And IMC Pharma Ltd. submitted their response on August 23, 2024.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">As part of the preliminary decision, the Commissioner determined that a temporary guarantee is
        not necessary at this stage, and the Company is now awaiting the Commissioner&#8217;s final decision. This decision must be approved by the Ministry of Economy&#8217;s Director General, following consultation with the Ministry of Finance&#8217;s Budgets Director.
        The local growers have filed an administrative petition against the Commissioner&#8217;s decision not to impose a temporary guarantee. The company submitted a request to the court to join the petition to argue against the claims of the local growers. A
        hearing on the petition has not yet been scheduled.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On November 10, 2024, the Commissioner published the final report on the investigation into
        cannabis imports from Canada, recommending the imposition of tax levies.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">According to the recommendations, a tax of 175% will be imposed on cannabis imports from
        Canadian companies that did not cooperate with the investigation, while major importers that participated will be subject to lower tax rates, starting at 2% and increasing incrementally. The Company is currently reviewing these recommendations and
        considering steps to prevent or mitigate the final decision.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On November 24, 2024, the Issuer submitted its formal response to the advisory committee, which
        is responsible for developing and submitting recommendations to the Minister of Treasury prior to the minister's final decision in this regard. It is currently uncertain when the advisory committee will conclude its deliberations or what outcome
        can be anticipated at this stage.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On December 11, 2024, the Advisory Committee held its first meeting where the Company
        participated and presented its arguments against the imposition of dumping tax. The Advisory Committee has not yet sent its recommendations to the Minister of Treasury nor published any recommendations. Following the first meeting, the Company sent
        a letter to the Advisory Committee, presenting both new and existing arguments for consideration before the Committee submits its recommendations to the Minister of Treasury.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On January 26, 2025, the Jerusalem District Court held a hearing on the administrative petition
        filed by the local growers seeking to impose a temporary guarantee. The judge recommended that the local growers withdraw their petition. The local growers subsequently submitted their consent to withdraw the petition without costs being imposed.
        The parties must submit their response regarding the request to waive costs by February 4, 2025.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">On February 4, 2025, the Company has submitted its response, stating that it is not waiving
        costs from the local growers. Following this, the Court decided to close the petition without costs.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;"><u>Germany - </u><font style="font-style: italic;"><u>BfArM Regulation</u></font></div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; margin-left: 36pt; line-height: 1.25; font-weight: bold;">The German Bundestag approved the federal government's draft law "on the controlled use of
        cannabis" (BT Drs. 20/8704, BT Drs. 20/8763, BT-Drs. 20/10426) on Friday, 23 February 2024. The draft passed in the German Bundesrat on Friday, 22 March 2024, and essentially came into force on April 1, 2024, in accordance with Art. 15 of the
        draft. Some components of Article 1 of the draft, which deals with so-called consumer cannabis, will not come into force until July 1, 2024 (according to Art. 15 para. 2 of the draft). This also has direct consequences for medicinal cannabis, which
        is the subject matter of Art. 2 (Medical Cannabis Act - MedCanG) and 3 (BtMG) of the draft. With the entry into force of the draft law, cannabis is no longer a narcotic by definition and is therefore no longer subject to the BtMG. The change in
        regulation has already led to rapid expansion within the first month, driven by the number of new patients entering into the market, highlighting the importance of a stable supply chain able to respond quickly to increases in demand.</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; line-height: 1.25;">The undersigned hereby certifies that:</div>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z8a9b477015ca41f3b0b2e2b80aab1a53" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">1.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The undersigned is a director and/or senior officer of the Issuer and has been duly authorized by a resolution of the board of directors of the Issuer to sign this
                Certificate of Compliance.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z1f71d0c60d5d4bbf8c18835951cda543" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">2.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>As of the date hereof there were no material information concerning the Issuer which has not been publicly disclosed.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z33a5374be1904878a362b0bda9f06e10" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">3.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>The undersigned hereby certifies to the Exchange that the Issuer is in compliance with the requirements of applicable securities legislation (as such term is defined
                in National Instrument 14-101) and all Exchange Requirements (as defined in CNSX Policy 1).</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <table cellspacing="0" cellpadding="0" id="z3a1efe0857e94c969dfb9f71fb5b6032" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt; vertical-align: top;">4.</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div>All of the information in this Form 7 Monthly Progress Report is true.</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25">&#160;</div>
      <div style="text-align: justify; line-height: 1.25;">Dated: April 3, 2025</div>
      <div style="line-height: 1.25">&#160;</div>
      <div style="line-height: 1.25">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;" id="z73fb610b552748d5bbc76b77544aed17">

            <tr>
              <td style="width: 70%; padding-bottom: 2px;"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);">Oren Shuster</td>
            </tr>
            <tr>
              <td style="width: 70%;" rowspan="1"><br>
              </td>
              <td style="width: 30%;" rowspan="1">Name of Director or Senior Officer</td>
            </tr>
            <tr>
              <td style="width: 70%;" rowspan="1"><br>
              </td>
              <td style="width: 30%;" rowspan="1"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 70%; padding-bottom: 2px;" rowspan="1"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">&#8220;<font style="font-style: italic;">Oren Shuster</font>&#8221;</td>
            </tr>
            <tr>
              <td style="width: 70%;" rowspan="1"><br>
              </td>
              <td style="width: 30%;" rowspan="1">Signature</td>
            </tr>
            <tr>
              <td style="width: 70%;" rowspan="1"><br>
              </td>
              <td style="width: 30%;" rowspan="1"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 70%; padding-bottom: 2px;" rowspan="1"><br>
              </td>
              <td style="width: 30%; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">Chief Executive Officer</td>
            </tr>
            <tr>
              <td style="width: 70%;" rowspan="1"><br>
              </td>
              <td style="width: 30%;" rowspan="1">Official Capacity</td>
            </tr>

        </table>
      </div>
      &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
      <table cellspacing="0" cellpadding="3" border="0" id="z69b262ab38654e25a2d87609cb89fada" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; text-align: left; color: rgb(0, 0, 0);">

          <tr>
            <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif; font-style: italic; font-weight: bold;">Issuer Details</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Name of Issuer</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">IM Cannabis Corp.</div>
            </td>
            <td style="width: 23.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">For Month End</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">March 2025</div>
            </td>
            <td style="width: 30.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Date of Report</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">YY/MM/D</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">2025/04/3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);" colspan="3">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Issuer Address</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">3606 &#8211; 833 Seymour Street</div>
            </td>
          </tr>
          <tr>
            <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">City/Province/Postal Code</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Vancouver, BC V6B 0G4</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
              </div>
            </td>
            <td style="width: 23.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Issuer Fax No.</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(&#160; &#160;&#160; )</div>
            </td>
            <td style="width: 30.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Issuer Telephone No.</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">+972 542815033</div>
            </td>
          </tr>
          <tr>
            <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>Contact Name</u></div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>Michal Lebovitz Nissimov</u></div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            </td>
            <td style="width: 23.92%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>Contact Position</u></div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>General Counsel</u></div>
            </td>
            <td style="width: 30.26%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>Contact Telephone No.</u></div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>+972 542815033</u></div>
            </td>
          </tr>
          <tr>
            <td style="width: 45.81%; vertical-align: top; border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Contact Email Address</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>Michal.l@imcannabis.com</u></div>
            </td>
            <td style="width: 54.19%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);" colspan="2">
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">Web Site Address</div>
              <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"><u>http://www.imcannabis.com/</u></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
